Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experience.
Zhai, Linzhu
Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experience. [electronic resource] - International journal of hematology Jan 2010 - 78-86 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1865-3774
10.1007/s12185-009-0461-8 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Prednisone--administration & dosage
Remission Induction
Retrospective Studies
Survival Analysis
Treatment Outcome
Vincristine--administration & dosage
Young Adult
Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin's lymphoma: single center, 15-year experience. [electronic resource] - International journal of hematology Jan 2010 - 78-86 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1865-3774
10.1007/s12185-009-0461-8 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Cyclophosphamide--administration & dosage
Doxorubicin--administration & dosage
Female
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Middle Aged
Prednisone--administration & dosage
Remission Induction
Retrospective Studies
Survival Analysis
Treatment Outcome
Vincristine--administration & dosage
Young Adult